Advertisement
Screener

BioCardia, Inc. (BCDA) Share-based Payment Arrangement, Expense

2.8 / 5 stars · 68/120 Roast Me

BioCardia, Inc. Share-based Payment Arrangement, Expense

BioCardia, Inc. (BCDA) reported Share-based Payment Arrangement, Expense of $109.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.

Financial Statements › Expense Statement › Operating Expenses

us-gaap:AllocatedShareBasedCompensationExpense · last filed 2026-08-12

  • BioCardia, Inc. share-based payment arrangement, expense for the quarter ending 2026-06-30 was $109.00K, a 11.22% increase year-over-year.
  • BioCardia, Inc. share-based payment arrangement, expense for the quarter ending 2026-03-31 was $113.00K, a 33.53% decline year-over-year.
  • BioCardia, Inc. share-based payment arrangement, expense for the quarter ending 2025-12-31 was $85.00K, a 51.70% decline year-over-year.
  • BioCardia, Inc. share-based payment arrangement, expense for the quarter ending 2025-09-30 was $77.00K, a 56.50% decline year-over-year.
  • BioCardia, Inc. share-based payment arrangement, expense for fiscal 2025 was $430.00K, a 41.97% decline from fiscal 2024.
  • BioCardia, Inc. share-based payment arrangement, expense for fiscal 2024 was $741.00K, a 28.06% decline from fiscal 2023.
  • BioCardia, Inc. share-based payment arrangement, expense for fiscal 2023 was $1.03M, a 12.93% decline from fiscal 2022.
  • BioCardia, Inc. share-based payment arrangement, expense for fiscal 2022 was $1.18M, a 28.78% decline from fiscal 2021.
Period endShare-based Payment Arrangement, ExpenseShare-based Payment Arrangement, Expense 3 monthShare-based Payment Arrangement, Expense 6 monthShare-based Payment Arrangement, Expense 9 monthShare-based Payment Arrangement, Expense 12 month
2026-06-30$109.00K
10-Q · filed 2026-08-12
$222.00K
10-Q · filed 2026-08-12
$307.00K
derived: sum of 3 quarters · filed 2026-08-12
$384.00K
derived: sum of 4 quarters · filed 2026-08-12
2026-03-31$113.00K
10-Q · filed 2026-05-15
$198.00K
derived: sum of 2 quarters · filed 2026-05-15
$275.00K
derived: sum of 3 quarters · filed 2026-05-15
$373.00K
derived: sum of 4 quarters · filed 2026-08-12
2025-12-31$85.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24
$162.00K
derived: sum of 2 quarters · filed 2026-03-24
$260.00K
derived: sum of 3 quarters · filed 2026-08-12
$430.00K
10-K · filed 2026-03-24
2025-09-30$77.00K
10-Q · filed 2025-11-12
$175.00K
derived: sum of 2 quarters · filed 2026-08-12
$345.00K
10-Q · filed 2025-11-12
$521.00K
derived: sum of 4 quarters · filed 2026-08-12
2025-06-30$98.00K
10-Q · filed 2026-08-12
$268.00K
10-Q · filed 2026-08-12
$444.00K
derived: sum of 3 quarters · filed 2026-08-12
$621.00K
derived: sum of 4 quarters · filed 2026-08-12
2025-03-31$170.00K
10-Q · filed 2026-05-15
$346.00K
derived: sum of 2 quarters · filed 2026-05-15
$523.00K
derived: sum of 3 quarters · filed 2026-05-15
$707.00K
derived: sum of 4 quarters · filed 2026-05-15
2024-12-31$176.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24
$353.00K
derived: sum of 2 quarters · filed 2026-03-24
$537.00K
derived: sum of 3 quarters · filed 2026-03-24
$741.00K
10-K · filed 2026-03-24
2024-09-30$177.00K
10-Q · filed 2025-11-12
$361.00K
derived: sum of 2 quarters · filed 2025-11-12
$565.00K
10-Q · filed 2025-11-12
$749.00K
derived: sum of 4 quarters · filed 2025-11-12
2024-06-30$184.00K
10-Q/A · filed 2025-10-29
$388.00K
10-Q/A · filed 2025-10-29
$572.00K
derived: sum of 3 quarters · filed 2025-10-29
$823.00K
derived: sum of 4 quarters · filed 2025-10-29
2024-03-31$204.00K
10-Q · filed 2025-05-14
$388.00K
derived: sum of 2 quarters · filed 2025-05-14
$639.00K
derived: sum of 3 quarters · filed 2025-05-14
$956.00K
derived: sum of 4 quarters · filed 2025-05-14
2023-12-31$184.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-26
$435.00K
derived: sum of 2 quarters · filed 2025-03-26
$752.00K
derived: sum of 3 quarters · filed 2025-03-26
$1.03M
10-K · filed 2025-03-26
2023-09-30$251.00K
10-Q · filed 2024-11-13
$568.00K
derived: sum of 2 quarters · filed 2024-11-13
$846.00K
10-Q · filed 2024-11-13
$1.13M
derived: sum of 4 quarters · filed 2024-11-13
2023-06-30$317.00K
10-Q · filed 2024-08-13
$595.00K
10-Q · filed 2024-08-13
$875.00K
derived: sum of 3 quarters · filed 2024-08-13
$1.16M
derived: sum of 4 quarters · filed 2024-08-13
2023-03-31$278.00K
10-Q · filed 2024-05-14
$558.00K
derived: sum of 2 quarters · filed 2024-05-14
$838.00K
derived: sum of 3 quarters · filed 2024-05-14
$1.14M
derived: sum of 4 quarters · filed 2024-05-14
2022-12-31$280.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27
$560.00K
derived: sum of 2 quarters · filed 2024-03-27
$864.00K
derived: sum of 3 quarters · filed 2024-03-27
$1.18M
10-K · filed 2024-03-27
2022-09-30$280.00K
10-Q · filed 2023-11-08
$584.00K
derived: sum of 2 quarters · filed 2023-11-08
$903.00K
10-Q · filed 2023-11-08
$1.33M
derived: sum of 4 quarters · filed 2023-11-08
2022-06-30$304.00K
10-Q · filed 2023-08-09
$623.00K
10-Q · filed 2023-08-09
$1.05M
derived: sum of 3 quarters · filed 2023-08-09
$1.48M
derived: sum of 4 quarters · filed 2023-08-09
2022-03-31$319.00K
10-Q · filed 2023-05-10
$743.00K
derived: sum of 2 quarters · filed 2023-05-10
$1.18M
derived: sum of 3 quarters · filed 2023-05-10
$1.56M
derived: sum of 4 quarters · filed 2023-05-10
2021-12-31$424.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29
$861.00K
derived: sum of 2 quarters · filed 2023-03-29
$1.25M
derived: sum of 3 quarters · filed 2023-03-29
$1.66M
10-K · filed 2023-03-29
2021-09-30$437.00K
10-Q · filed 2022-11-09
$821.00K
derived: sum of 2 quarters · filed 2022-11-09
$1.24M
10-Q · filed 2022-11-09
$1.86M
derived: sum of 4 quarters · filed 2022-11-09
2021-06-30$384.00K
10-Q · filed 2022-08-10
$800.00K
10-Q · filed 2022-08-10
$1.42M
derived: sum of 3 quarters · filed 2022-08-10
$2.16M
derived: sum of 4 quarters · filed 2022-08-10
2021-03-31$416.00K
10-Q · filed 2022-05-11
$1.03M
derived: sum of 2 quarters · filed 2022-05-11
$1.77M
derived: sum of 3 quarters · filed 2022-05-11
$2.43M
derived: sum of 4 quarters · filed 2022-05-11
2020-12-31$619.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29
$1.36M
derived: sum of 2 quarters · filed 2022-03-29
$2.01M
derived: sum of 3 quarters · filed 2022-03-29
$2.95M
10-K · filed 2022-03-29
2020-09-30$737.00K
10-Q · filed 2021-11-10
$1.39M
derived: sum of 2 quarters · filed 2021-11-10
$2.33M
10-Q · filed 2021-11-10
$2.91M
derived: sum of 4 quarters · filed 2021-11-10
2020-06-30$655.00K
10-Q · filed 2021-08-12
$1.60M
10-Q · filed 2021-08-12
$2.18M
derived: sum of 3 quarters · filed 2021-08-12
$2.93M
derived: sum of 4 quarters · filed 2021-08-12
2020-03-31$941.00K
10-Q · filed 2021-05-13
$1.52M
derived: sum of 2 quarters · filed 2021-05-13
$2.28M
derived: sum of 3 quarters · filed 2021-05-13
$2.97M
derived: sum of 4 quarters · filed 2021-05-13
2020-01-29$412.00K
10-K · filed 2022-03-29
2019-12-31$580.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30
$1.34M
derived: sum of 2 quarters · filed 2021-03-30
$2.03M
derived: sum of 3 quarters · filed 2021-03-30
$2.72M
10-K · filed 2021-03-30
2019-09-30$756.00K
10-Q · filed 2020-11-10
$1.45M
derived: sum of 2 quarters · filed 2020-11-10
$2.14M
10-Q · filed 2020-11-10
$2.83M
derived: sum of 4 quarters · filed 2020-11-10
2019-06-30$696.00K
10-Q · filed 2020-08-13
$1.39M
10-Q · filed 2020-08-13
$2.08M
derived: sum of 3 quarters · filed 2020-08-13
$2.81M
derived: sum of 4 quarters · filed 2020-08-13
2019-03-31$690.00K
10-Q · filed 2020-05-15
$1.38M
derived: sum of 2 quarters · filed 2020-05-15
$2.11M
derived: sum of 3 quarters · filed 2020-05-15
$2.85M
derived: sum of 4 quarters · filed 2020-05-15
2018-12-31$691.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-04-09
$1.42M
derived: sum of 2 quarters · filed 2020-04-09
$2.16M
derived: sum of 3 quarters · filed 2020-04-09
$2.77M
10-K · filed 2020-04-09
2018-09-30$730.00K
10-Q · filed 2019-11-19
$1.47M
derived: sum of 2 quarters · filed 2019-11-19
$2.08M
10-Q · filed 2019-11-19
$2.79M
derived: sum of 4 quarters · filed 2020-04-09
2018-06-30$738.00K
10-Q · filed 2019-08-14
$1.35M
10-Q · filed 2019-08-14
$2.06M
derived: sum of 3 quarters · filed 2020-04-09
$2.76M
derived: sum of 4 quarters · filed 2020-04-09
2018-03-31$615.00K
10-Q · filed 2019-05-15
$1.32M
derived: sum of 2 quarters · filed 2020-04-09
$2.02M
derived: sum of 3 quarters · filed 2020-04-09
$2.70M
derived: sum of 4 quarters · filed 2020-04-09
2017-12-31$708.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-04-09
$1.41M
derived: sum of 2 quarters · filed 2020-04-09
$2.08M
derived: sum of 3 quarters · filed 2020-04-09
$2.71M
10-K · filed 2020-04-09
2017-09-30$701.00K
10-Q · filed 2018-11-08
$1.38M
derived: sum of 2 quarters · filed 2018-11-08
$2.00M
10-Q · filed 2018-11-08
$2.80M
derived: sum of 4 quarters · filed 2019-04-02
2017-06-30$676.00K
10-Q · filed 2018-08-09
$1.30M
10-Q · filed 2018-08-09
$2.10M
derived: sum of 3 quarters · filed 2019-04-02
$2.18M
derived: sum of 4 quarters · filed 2019-04-02
2017-03-31$622.00K
10-Q · filed 2018-05-10
$1.42M
derived: sum of 2 quarters · filed 2019-04-02
$1.51M
derived: sum of 3 quarters · filed 2019-04-02
$1.53M
derived: sum of 4 quarters · filed 2019-04-02
2016-12-31$797.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-02
$884.00K
derived: sum of 2 quarters · filed 2019-04-02
$912.00K
derived: sum of 3 quarters · filed 2019-04-02
$942.00K
10-K · filed 2019-04-02
2016-09-30$87.00K
10-Q · filed 2017-11-09
$115.00K
derived: sum of 2 quarters · filed 2017-11-09
$145.00K
10-Q · filed 2017-11-09
2016-06-30$28.00K
10-Q · filed 2017-08-14
$58.00K
10-Q · filed 2017-08-14
2016-03-31$30.00K
10-Q · filed 2017-05-11
2015-12-31$283.00K
10-K · filed 2018-03-16

Similar stocks

Stock NameCountryMarket CapPE Ratio
DYADIC INTERNATIONAL INC (DYAI)United States$0.016B
Passage BIO, Inc. (PASG)United States$0.015B-0.43
Pluri Inc. (PLUR)$0.014B
INTENSITY THERAPEUTICS, INC. (INTS)United States$0.013B-1.08
BRAINSTORM CELL THERAPEUTICS INC. (BCLI)United States$0.013B-1.05
Jasper Therapeutics, Inc. (JSPR)United States$0.020B-0.37
Estrella Immunopharma, Inc. (ESLA)United States$0.020B
IN8BIO, INC. (INAB)United States$0.012B-0.76
Senti Biosciences Holdings, Inc. (SNTI)United States$0.011B-0.70
TScan Therapeutics, Inc. (TCRX)United States$0.008B-1.23